Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 19, 2023

SELL
$131.14 - $157.47 $38,424 - $46,138
-293 Reduced 14.5%
1,727 $0
Q2 2022

Aug 08, 2022

BUY
$155.97 - $200.09 $315,059 - $404,181
2,020 New
2,020 $347,000
Q4 2020

Feb 09, 2021

SELL
$157.07 - $174.35 $424,089 - $470,745
-2,700 Closed
0 $0
Q3 2020

Oct 20, 2020

BUY
$137.1 - $165.37 $10,419 - $12,568
76 Added 2.9%
2,700 $446,000
Q2 2020

Jul 20, 2020

BUY
$111.92 - $142.53 $50,140 - $63,853
448 Added 20.59%
2,624 $360,000
Q1 2020

May 12, 2020

BUY
$92.66 - $144.94 $201,628 - $315,389
2,176 New
2,176 $256,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Stanley Laman Group, Ltd. Portfolio

Follow Stanley Laman Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.